Exact Mass: 462.27161259999997
Exact Mass Matches: 462.27161259999997
Found 221 metabolites which its exact mass value is equals to given mass value 462.27161259999997
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Retinyl beta-glucuronide
Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate
1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:2(11Z,14Z)/0:0)
LysoPA(20:2(11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:2(11Z,14Z)/0:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Trichomonacid
C27H34N4O3 (462.26307740000004)
KAZINOL Q
2beta,9alpha,14alpha-Triacetoxy-3alpha-hydroxy-1(15),8(19)-trinervitadiene
14,15,16-triacetoxy-15,16-epoxy-ent-cleroda-4(18),12E-diene
1alpha-hydroxy-7alpha,14alpha,18-triacetoxy-isopimara-8,15-diene|7alpha,14alpha,18-triacetoxy-8,15-isopimaradien-1alpha-ol
anti-thiobinupharidine sulphoxide
C26H39FN2O2S (462.27161259999997)
(1S,2R,3S,8S,9S,10S,13S,14S,16S,17R,22R,25R)-21-nor-18beta,27alpha-dimethyl-1beta,2beta,3beta-trihydroxy-25-spirost-4-en-19beta-oic acid
1-[1-(acetyloxy)ethyl]octahydro-6-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-7-(propan-2-yl)-1H-inden-5-yl (2E)-3-methylpent-2-enoate
2-epicaseabalansin C|rel-(2R,4S,5R,8S,9S,10R,18S,19R)-2,18,19-triacetoxycleroda-13(16),14-dien-18,19-oxolane
6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6-butyrate 17 acetate
(3S, 4E, 26E, 28S)-form-3, 28-Dihydroxy-4, 26-triacontadiene-1, 12, 18, 29-tetrahyne-14, 17-dione|(3S,28S)-3,28-dihydroxy-4,27-triacontadiene-1,12,18,29-tetrayne-4,17-dione|adociacetylene D
methyl-4E-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate|methyl-9beta-senecioyloxy-14-O-(2-methylbutyryl)-oxyphylloate|methyl-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate
5,14,19-Tri-Ac-(5R,13(15)E,16Z)-13(15),16-Spatadiene-5,14,18,19-tetrol
14,15,16-Triacetoxy-15,16-epoxy-ent-cleroda-3,12Z-diene
15-O-acetyl-5beta-hydroxyisocharaciol-3-isobutyrate
6,12,13-Tri-Ac-(1alpha,5beta,6beta,9alpha,12xi,13xi)-3,10,14-Prenylguaiatriene-6,9,12,13-tetrol
Thr Lys Ser Lys
Gly Lys Lys Met
Gly Lys Met Lys
Gly Met Lys Lys
Lys Gly Lys Met
Lys Gly Met Lys
Lys Lys Gly Met
Lys Lys Met Gly
Lys Lys Ser Thr
Lys Lys Thr Ser
Lys Met Gly Lys
Lys Met Lys Gly
Lys Ser Lys Thr
Lys Ser Thr Lys
Lys Thr Lys Ser
Lys Thr Ser Lys
Met Gly Lys Lys
Met Lys Gly Lys
Met Lys Lys Gly
Ser Lys Lys Thr
Ser Lys Thr Lys
Ser Thr Lys Lys
Thr Lys Lys Ser
Thr Ser Lys Lys
2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide,hydrochloride
Fedovapagon
C27H34N4O3 (462.26307740000004)
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist
1-(11Z,14Z-Eicosadienoyl)-glycero-3-phosphoric acid
1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-[(1-ethyl-2-pyrrolidinyl)methyl]-3-(2-methoxyphenyl)urea
C27H34N4O3 (462.26307740000004)
[(8R,9S,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(1R)-7-methoxy-1-(4-oxanylmethyl)-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C27H34N4O3 (462.26307740000004)
[(8R,9S,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
LPEt(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMeLPA(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
methyl 10-hydroxy-2,4a,6a,9,13,14a-hexamethyl-11-oxo-3,4,5,6,14,14b-hexahydro-1h-picene-2-carboxylate
2-[11-(4-hydroperoxy-4-methylpent-2-en-1-yl)-3-methoxy-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(4ar,5s,9as)-9a-[(4ar,5s,9ar)-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-9a-yl]-3,4a,5-trimethyl-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-2-one
(1e)-2-[(1s,2s,7s)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
methyl (2s,3ar,4s,5s,5'as,7's,9'ar)-3a-(hydroxymethyl)-1',1',4,5'a,7,7'-hexamethyl-3',6-dioxo-4,4',5,5',7',8',9',9'a-octahydro-3h-spiro[1-benzofuran-2,6'-[2]benzoxepine]-5-carboxylate
methyl 10-hydroxy-2,4a,6,9,12b,14a-hexamethyl-11-oxo-3,4,5,13,14,14b-hexahydro-1h-picene-2-carboxylate
(3s,4e,26e,28s)-3,28-dihydroxytriaconta-4,26-dien-1,12,18,29-tetrayne-14,17-dione
{2-hydroxy-6-[1-hydroxy-3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl 3-hydroxybutanoate
2-[2-(4-hydroperoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1s)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-2,6,11,15-tetramethylheptadeca-2,4,6,8,10,12,14,16-octaenoic acid
10-deacetyltaxuyunnanine c
{"Ingredient_id": "HBIN000092","Ingredient_name": "10-deacetyltaxuyunnanine c","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4787","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methyl-5-epi-vibsanin k
{"Ingredient_id": "HBIN002145","Ingredient_name": "18-o-methyl-5-epi-vibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14397","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methylvibsanin k
{"Ingredient_id": "HBIN002148","Ingredient_name": "18-o-methylvibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10695370","DrugBank_id": "NA"}
1-dehydroxybaccatin
{"Ingredient_id": "HBIN002472","Ingredient_name": "1-dehydroxybaccatin","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(C(CC(C2(C)C)CC1OC(=O)C)C4COC4CC3OC(=O)C)C)OC(=O)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25938","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101225011","DrugBank_id": "NA"}
2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN005284","Ingredient_name": "2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene","Alias": "2\u03b1-hydroxy-5\u03b1,10\u03b2,14\u03b2-triacetoxytaxa-4(20),11-diene","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(CCC(C(=C)C3C(C(C2(C)C)C(C1)OC(=O)C)O)OC(=O)C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31281;10778","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-epi-neovibsanin d
{"Ingredient_id": "HBIN013182","Ingredient_name": "7-epi-neovibsanin d","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(CC=C2C13C(CC(O3)(C)OC)OC2)(C)CC=CC(C)(C)OO)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15464","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11385697","DrugBank_id": "NA"}
biatractylolide
{"Ingredient_id": "HBIN018397","Ingredient_name": "biatractylolide","Alias": "Biatractylolide","Ingredient_formula": "C30H38O4","Ingredient_Smile": "CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)C45CC6(CCCC(=C)C6CC4=C(C(=O)O5)C)C)C","Ingredient_weight": "462.6 g/mol","OB_score": "17.44616598","CAS_id": "NA","SymMap_id": "SMIT02742","TCMID_id": "32490","TCMSP_id": "MOL000062","TCM_ID_id": "6226","PubChem_id": "10813930","DrugBank_id": "NA"}
biepiasterolide
{"Ingredient_id": "HBIN018493","Ingredient_name": "biepiasterolide","Alias": "NA","Ingredient_formula": "C30H38O4","Ingredient_Smile": "CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)C45CC6(CCCC(=C)C6CC4=C(C(=O)O5)C)C)C","Ingredient_weight": "462.62","OB_score": "NA","CAS_id": "252027-27-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6212","PubChem_id": "11351701","DrugBank_id": "NA"}
methyl 10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,3,4,13,14,14b-hexahydropicene-2-carboxylate
(1s,2s,3r,4r,5r,7s,8r,11s,12r,17s)-12-(acetyloxy)-5,8,11-trimethyl-15-methylidene-14-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate
(2r,3r,4s,5s,6r)-2-{[(1s,6s,10r,13r,14r)-14-hydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadeca-2,4(8)-dien-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-({14-hydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadeca-2,4(8)-dien-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (2r,4as,6as,14as,14br)-10-hydroxy-2,4a,6a,9,13,14a-hexamethyl-11-oxo-3,4,5,6,14,14b-hexahydro-1h-picene-2-carboxylate
(2s,4ar,4bs,6s,6as,8s,10ar,10bs,11s,12as)-6,11-dihydroxy-2,4b,7,7,10a,12a-hexamethyl-12-methylidene-1,4-dioxo-decahydrophenanthro[1,2-c]pyran-8-yl acetate
(4ar,8as,9ar)-9a-[(4as,8ar,9as)-3,8a-dimethyl-5-methylidene-2-oxo-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-9a-yl]-3,8a-dimethyl-5-methylidene-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
(1r,2s,3s,5s,8s,10s,14s)-10,14-bis(acetyloxy)-2-hydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl acetate
(1r,3r,3ar,5r,6as,7r,8r,10as)-1,5-bis(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-decahydronaphtho[1,8a-c]furan-3-yl acetate
(3z,3ar,5ar,9ar,9br)-3a,6,6,9a-tetramethyl-3-[(3e,5e)-6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-hexahydro-1h-cyclopenta[a]naphthalene-2,7-dione
4-{3-[8-hydroxy-2,2-dimethyl-5-(3-methylbut-2-en-1-yl)chromen-6-yl]propyl}-6-(2-methylbut-3-en-2-yl)benzene-1,3-diol
10-hydroxy-8,9,12,15,16,24-hexamethyl-22,26-dioxaheptacyclo[12.7.4.1²,¹³.0¹,²⁵.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]hexacosa-4,11,20,24-tetraen-23-one
(4ar,8as,9ar)-9a-[(4ar,8as,9ar)-3,8a-dimethyl-5-methylidene-2-oxo-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-9a-yl]-3,8a-dimethyl-5-methylidene-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
(1s,2s,3r,4r,7r,8s,11s,14r,17s)-14-(acetyloxy)-4,8,11-trimethyl-15-methylidene-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate
methyl 18-isopropyl-17-methoxy-4,7,11,14-tetramethyl-10,16-dioxo-6,15-dioxatricyclo[12.4.0.0⁵,⁹]octadeca-3,17-diene-8-carboxylate
methyl (2r,4ar,6as,12bs,14as,14br)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,3,4,13,14,14b-hexahydropicene-2-carboxylate
3a-(acetyloxy)-13-hydroxy-2,5,8,8-tetramethyl-12-methylidene-4,9-dioxo-1h,2h,3h,7h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl 2-methylpropanoate
(1's,2r,4'r,6r,6''r,9r,9''s,9as,9''as)-6-fluoro-6''-(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-2,2'-thiolane-4',3''-quinolizin]-1'-ium-1'-olate
C26H39FN2O2S (462.27161259999997)
3,5-bis(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-decahydronaphtho[4,4a-c]furan-1-yl acetate
(1r,2s,3s,4r,5r,8s,9s,12z,14s,17s)-5-(acetyloxy)-2-hydroxy-4,8,12,17-tetramethyl-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-9-yl butanoate
(1r,3r,6s,8s,10r,11r,12s,15s)-3,8-bis(acetyloxy)-11-hydroxy-6,12,16-trimethyl-2-methylidenetricyclo[7.5.2.0¹²,¹⁵]hexadec-9(16)-en-10-yl acetate
[(1s,2r,6s)-2-hydroxy-6-[(1s,2e)-1-hydroxy-3-methyl-5-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]pent-2-en-1-yl]-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl (3r)-3-hydroxybutanoate
(4e,14s,15z,17s,26e,28s)-14,17,28-trihydroxytriaconta-4,15,26-trien-1,12,18,29-tetrayn-3-one
3-[2-(1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl)ethylidene]-4,5-bis(acetyloxy)oxolan-2-yl acetate
{2-hydroxy-6-[(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)methyl]-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl 3-hydroxybutanoate
(3z,3as,5ar,9ar,9bs)-3a,6,6,9a-tetramethyl-3-[(3z,5e)-6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-hexahydro-1h-cyclopenta[a]naphthalene-2,7-dione
(1's,2r,2's,4's,5r,8'r,9's,12's,13's,14's,15'r,16'r)-14',15',16'-trihydroxy-5,9'-dimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-ene-13'-carboxylic acid
methyl 5,9-dimethyl-14-methylidene-6-[(3-phenylprop-2-enoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
(9r,13r,16r,17r)-8,8,13,17-tetramethyl-16-[(1s)-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-6-one
14',15',16'-trihydroxy-5,9'-dimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-ene-13'-carboxylic acid
(1s,2s,8r,9s,10r,13s,14s,15s,16s)-10-hydroxy-8,9,12,15,16,24-hexamethyl-22,26-dioxaheptacyclo[12.7.4.1²,¹³.0¹,²⁵.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]hexacosa-4,11,20,24-tetraen-23-one
(2r,3r,4s,5r,6r)-2-{[(1r,6s,10r,13r,14r)-14-hydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadeca-2,4(8)-dien-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(4as,8ar,9as)-9a-[(4as,8ar,9as)-3,8a-dimethyl-5-methylidene-2-oxo-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-9a-yl]-3,8a-dimethyl-5-methylidene-4h,4ah,6h,7h,8h,9h-naphtho[2,3-b]furan-2-one
methyl (2r,4ar,12bs,14as,14br)-10-hydroxy-2,4a,6,9,12b,14a-hexamethyl-11-oxo-3,4,5,13,14,14b-hexahydro-1h-picene-2-carboxylate
(3e,3as,5ar,9ar,9bs)-3a,6,6,9a-tetramethyl-3-[6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-hexahydro-1h-cyclopenta[a]naphthalene-2,7-dione
1,19-bis(3-hydroxyazetidin-1-yl)nonadeca-5,14-diene-1,8,12,19-tetrone
(1r,3r,3ar,5s,6as,7r,8r,10as)-1,5-bis(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-decahydronaphtho[1,8a-c]furan-3-yl acetate
14-(acetyloxy)-4,8,11-trimethyl-15-methylidene-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate
(2e,4e,6e,8e)-17-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-2,6,11,15-tetramethylheptadeca-2,4,6,8,10,12,14,16-octaenoic acid
(4ar,5s,9ar)-9a-[(4ar,5s,9ar)-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-9a-yl]-3,4a,5-trimethyl-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-2-one
3a,6,6,9a-tetramethyl-3-[6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-hexahydro-1h-cyclopenta[a]naphthalene-2,7-dione
(1e)-2-[(1s,3s,5s,11s,12r)-11-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-3-methoxy-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(2e)-5-[(1s,4as,5r,8as)-2,5-bis[(acetyloxy)methyl]-5,8a-dimethyl-6-oxo-4,4a,7,8-tetrahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl acetate
(3z,3as,5ar,9ar,9bs)-3a,6,6,9a-tetramethyl-3-[(3e,5e)-6-(5-methyl-6-oxopyran-2-yl)hepta-3,5-dien-2-ylidene]-hexahydro-1h-cyclopenta[a]naphthalene-2,7-dione
(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1r)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-2,6,11,15-tetramethylheptadeca-2,4,6,8,10,12,14,16-octaenoic acid
(1e)-2-[(1s,2s,7r)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(2s,3r,4z,5s)-4-{2-[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethylidene}-3,5-bis(acetyloxy)oxolan-2-yl acetate
methyl 5,9-dimethyl-14-methylidene-15-[(3-phenylprop-2-enoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
4-[2-(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)ethylidene]-3,5-bis(acetyloxy)oxolan-2-yl acetate
6-fluoro-6''-(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-2,2'-thiolane-4',3''-quinolizin]-1'-ium-1'-olate
C26H39FN2O2S (462.27161259999997)